BMY:NYE-Bristol-Myers Squibb Company (USD)

EQUITY | Drug Manufacturers - General | New York Stock Exchange

Last Closing

USD 44.85

Change

0.00 (0.00)%

Market Cap

USD 93.95B

Volume

0.02B

Analyst Target

USD 73.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

-11.55 (-1.50%)

USD 733.28B
JNJ Johnson & Johnson

+0.06 (+0.04%)

USD 360.64B
MRK Merck & Company Inc

-0.17 (-0.13%)

USD 318.60B
ABBV AbbVie Inc

+0.35 (+0.22%)

USD 283.25B
NVS Novartis AG ADR

+1.89 (+1.89%)

USD 202.14B
PFE Pfizer Inc

-0.17 (-0.60%)

USD 157.25B
GSK GlaxoSmithKline PLC ADR

+0.40 (+0.90%)

USD 90.02B
OGN Organon & Co

-0.09 (-0.44%)

USD 4.56B

ETFs Containing BMY

MEDX Horizon Kinetics Medical .. 5.43 % 0.00 %

-0.20 (0.28%)

USD 0.02B
LIFE-B:CA Evolve Global Healthcare .. 5.22 % 0.00 %

+0.07 (+0.28%)

CAD 0.01B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.72 % 0.00 %

+0.15 (+0.28%)

USD 3.48M
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.60 % 0.00 %

+0.20 (+0.28%)

USD 0.15B
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.72 % 0.00 %

+0.04 (+0.28%)

USD 0.01B
LUMV:LSE Ossiam US Minimum Varianc.. 3.00 % 0.00 %

+47.50 (+0.28%)

USD 0.01B
USMV:LSE Ossiam US Minimum Varianc.. 3.00 % 0.00 %

+0.50 (+0.28%)

USD 0.01B
MVUS:PA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 0.01B
SPMV:PA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 7.79M
OSX2:F Ossiam Lux - Ossiam US Mi.. 3.00 % 0.00 %

+0.30 (+0.28%)

N/A
OSX2:XETRA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

+0.80 (+0.28%)

USD 0.12B
DHS:SW WisdomTree US Equity Inco.. 2.98 % 0.00 %

+0.16 (+0.28%)

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.98 % 0.00 %

+0.57 (+0.28%)

USD 0.29M
TDIV:SW VanEck Morningstar Develo.. 2.85 % 0.00 %

+0.50 (+0.28%)

USD 0.70B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 2.55 % 0.00 %

+0.22 (+0.28%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.55 % 0.00 %

+0.26 (+0.28%)

USD 0.64M
WTEU:F WisdomTree US Equity Inco.. 2.55 % 0.00 %

+0.18 (+0.28%)

USD 0.11B
WTD9:XETRA WisdomTree Issuer ICAV - .. 2.55 % 0.00 %

+0.13 (+0.28%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 2.55 % 0.00 %

+0.09 (+0.28%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 2.55 % 0.00 %

+0.10 (+0.28%)

USD 0.11B
DHS:LSE WisdomTree US Equity Inco.. 2.52 % 0.00 %

+14.85 (+0.28%)

USD 0.03B
DHSA:LSE WisdomTree US Equity Inco.. 2.52 % 0.00 %

+0.07 (+0.28%)

USD 0.04B
DHSD:LSE WisdomTree US Equity Inco.. 2.52 % 0.00 %

+0.08 (+0.28%)

USD 0.03B
DHSG:LSE WisdomTree US Equity Inco.. 2.52 % 0.00 %

+7.50 (+0.28%)

USD 0.72M
DHSP:LSE WisdomTree US Equity Inco.. 2.52 % 0.00 %

+6.00 (+0.28%)

USD 0.04B
VDIV:F VanEck Vectors ETFs N.V... 2.35 % 0.00 %

+0.25 (+0.28%)

USD 0.64B
VDIV:XETRA VanEck Morningstar Develo.. 2.35 % 0.00 %

+0.33 (+0.28%)

USD 0.64B
TDGB:LSE VanEck Morningstar Develo.. 2.34 % 0.00 %

+0.25 (+0.28%)

USD 0.68B
TDIV:LSE VanEck Morningstar Develo.. 2.31 % 0.00 %

+0.32 (+0.28%)

USD 0.69B
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
DHS WisdomTree U.S. High Divi.. 1.78 % 0.38 %

+0.01 (+0.28%)

USD 1.07B
UVDV 1.72 % 0.00 %

N/A

N/A
JAVA JPMorgan Active Value ETF 1.53 % 0.00 %

+0.15 (+0.28%)

USD 1.04B
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

-1.00 (0.28%)

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

-0.01 (0.28%)

USD 0.30B
SPXB ProShares S&P 500® Bond .. 1.32 % 0.15 %

N/A

USD 9.13M
DEW WisdomTree Global High Di.. 1.20 % 0.58 %

+0.10 (+0.28%)

USD 0.10B
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

-1.50 (0.28%)

USD 0.18B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

-0.55 (0.28%)

USD 0.05B
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

-0.02 (0.28%)

USD 0.18B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

-0.02 (0.28%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

-0.02 (0.28%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.02 (+0.28%)

USD 0.03B
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

-0.03 (0.28%)

USD 0.18B
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.21B
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.05B
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

-0.25 (0.28%)

CAD 0.47B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

-0.03 (0.28%)

USD 0.08B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

-2.00 (0.28%)

USD 0.06B
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

+0.90 (+0.28%)

CAD 0.01B
FTLS First Trust Long/Short Eq.. 0.00 % 1.59 %

-0.31 (0.28%)

USD 1.13B
GBF iShares Government/Credit.. 0.00 % 0.20 %

-0.28 (0.28%)

USD 0.22B
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

-0.47 (0.28%)

USD 0.66B
JHMH 0.00 % 0.46 %

N/A

N/A
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

-0.12 (0.28%)

USD 1.02B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

-0.05 (0.28%)

USD 0.35B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.09 (0.28%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.04 (+0.28%)

CAD 0.09B
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

+0.16 (+0.28%)

USD 1.74B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

+0.05 (+0.28%)

CAD 0.05B
RUD-U:CA RBC Quant U.S. Dividend L.. 0.00 % 0.00 %

N/A

N/A
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RUD:CA RBC Quant US Dividend Lea.. 0.00 % 0.43 %

+0.19 (+0.28%)

CAD 0.48B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.09 (0.28%)

USD 1.11M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.09 (0.28%)

USD 1.11M
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

-1.25 (0.28%)

USD 0.08B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-0.62 (0.28%)

USD 0.13B
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

+0.10 (+0.28%)

CAD 0.01B
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

-0.01 (0.28%)

USD 8.64M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.59% 11% F 12% F
Dividend Return 2.34% 89% A- 84% B
Total Return -10.25% 22% F 14% F
Trailing 12 Months  
Capital Gain -32.83% 22% F 7% C-
Dividend Return 3.50% 44% F 53% F
Total Return -29.32% 22% F 8% B-
Trailing 5 Years  
Capital Gain -3.17% 25% F 43% F
Dividend Return 22.06% 75% C 77% C+
Total Return 18.89% 25% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 3.01% 44% F 52% F
Dividend Return 6.23% 44% F 54% F
Total Return 3.21% 56% F 64% D
Risk Return Profile  
Volatility (Standard Deviation) 19.04% 33% F 58% F
Risk Adjusted Return 32.69% 44% F 55% F
Market Capitalization 93.95B 33% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.66 89% 67%
Price/Book Ratio 3.32 78% 26%
Price / Cash Flow Ratio 6.56 89% 53%
Price/Free Cash Flow Ratio 6.56 100% 58%
Management Effectiveness  
Return on Equity -25.33% 13% 12%
Return on Invested Capital 24.13% 78% 91%
Return on Assets 5.39% 33% 75%
Debt to Equity Ratio 124.54% 38% 28%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.